Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

570
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
570

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ExtracorporeaL life support and Modification Of Hemostasis: the ELMOH trial: hemostatic changes during the first 48 h of VV- and VA-ECMO: a prospective multicenter cohort study.

Critical care (London, England)·2026
Same author

ROTEM-detected hypocoagulability is associated with major non-portal hypertensive bleeding in cirrhosis.

Hepatology communications·2026
Same author

The influence of antiphospholipid antibodies on prothrombin time and international normalized ratio: a scoping review.

Critical reviews in clinical laboratory sciences·2025
Same author

Randomized Cross-Over Study to Examine Associations Between Dialyzer Clotting, Uremic Toxin Removal, and Hemocompatibility During Post-Dilution Hemodiafiltration With Reduced Anticoagulation.

Artificial organs·2025
Same author

A high level of sTREM-1 predicts occurrence of thrombosis, obstetrical event or death in a prospective cohort of patients with antiphospholipid antibodies and/or systemic lupus. Results of the APLART study.

Lupus·2025
Same author

ADAMTS13 Activity Testing: Evaluation of Two Automated Platforms for Diagnosis and Follow-Up of Thrombotic Thrombocytopenic Purpura.

International journal of laboratory hematology·2025

Related Experiment Video

Updated: May 17, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.7K

Lupus Anticoagulant Testing in Challenging Situations: Navigating Complexities.

Katrien M J Devreese1

  • 1Coagulation Laboratory, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

International Journal of Laboratory Hematology
|May 16, 2025
PubMed
Summary
This summary is machine-generated.

Accurate diagnosis of antiphospholipid syndrome (APS) requires careful lupus anticoagulant (LA) testing. Understanding LA measurement challenges and interferences is crucial for reliable laboratory results.

Keywords:
antiphospholipid antibodiesantiphospholipid syndromediagnosislupus anticoagulanttesting

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

359

Related Experiment Videos

Last Updated: May 17, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.7K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

359

Area of Science:

  • Clinical immunology
  • Hematology
  • Laboratory medicine

Background:

  • Antiphospholipid syndrome (APS) diagnosis relies on detecting persistent antiphospholipid antibodies (aPL).
  • Lupus anticoagulant (LA) is a key laboratory criterion and risk factor in APS diagnosis.
  • LA testing is complex and prone to interferences, impacting diagnostic accuracy.

Purpose of the Study:

  • To detail the technical aspects and interpretation of LA testing for APS diagnosis.
  • To highlight challenges and potential pitfalls in LA measurement.
  • To emphasize the importance of expertise and interdisciplinary communication in LA testing.

Main Methods:

  • Review of LA testing guidelines and methodologies.
  • Discussion of factors influencing LA test results, including sample preparation and anticoagulant interference.
  • Analysis of interpretative aspects and clinical correlation.

Main Results:

  • LA testing is critical but technically demanding, requiring adherence to guidelines.
  • Numerous factors can interfere with LA measurement, leading to potential false results.
  • Persistent LA positivity is essential for diagnostic confirmation.

Conclusions:

  • Accurate LA testing is fundamental for APS diagnosis, necessitating a deep understanding of technical nuances.
  • Addressing methodological challenges and interferences is vital for reliable LA results.
  • Close collaboration between laboratory professionals and clinicians is mandatory for effective APS diagnosis and patient management.